The purpose of this activity is to enable the learner to develop a better understanding of the pathophysiology and hemodynamic parameters of PAH and treatment options for this disease, and the role of the nurse in helping these patients better understand and manage their disease.

Recorded Enduring Education Activity

Expiration Date: December 2020
1.3 Contact Hours ANCC
Member Price: $5.00
Non-Member Price $15.00

Learner Outcomes:

1. Describe the pathophysiology of pulmonary hypertension
2. Identify hemodynamic parameters associated with pulmonary hypertension
3. Describe the FDA approved medications used in the management of PAH including indications for use, dosing, side effects, and monitoring .
4. Review components/methods of patient education regarding PAH and treatments
5. Discuss disease management challenges associated with PAH

REQUIREMENT FOR SUCCESSFUL COMPLETION

• Attendance at the entire event.
• Complete/submit evaluation form.
• Access and print your certificate.

PLANNING COMMITTEE

Kelley Anderson, PhD, FNP, CHFN-K

Planning committee members have no conflicts of interest that relate to this activity.

FACULTY

Traci Stewart, RN, MSN, CHFN

Faculty has no conflicts of interest that relate to this activity.

ACCREDITATION STATEMENT

This activity is provided by the American Association of Heart Failure Nurses (AAHFN).

The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

DISCLAIMER

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

COMMERCIAL SUPPORT

There is no commercial support for this webinar